Nicholas Britt

  • Assistant Professor
School of Pharmacy - Pharmacy Practice
913-588-5391
Office
Wescoe 6010
KU Medical Center
3901 Rainbow Boulevard
66160

Education

  • Infectious Diseases Pharmacy Residency, Barnes-Jewish Hospital, St. Louis, MO (2016-2017)
  • Pharmacy Practice Residency, Barnes-Jewish Hospital, St. Louis, MO (2015-2016)
  • Pharm.D., University of Kansas School of Pharmacy, Lawrence, KS (2010-2015)
  • M.S., Clinical and Translational Research, University of Kansas School of Medicine, Kansas City, KS (2013-2014)
  • B.S., Pharmaceutical Studies, University of Kansas School of Pharmacy, Lawrence, KS (2010-2013)

Experience

Professional Experience

  • Assistant Professor of Pharmacy Practice, University of Kansas, Lawrence, KS (2017 - present)
  • Assistant Professor of Internal Medicine, University of Kansas Medical Center, Kansas City, KS (2017 - present)
  • Clinical Pharmacist, Infectious Diseases, University of Kansas Hospital, Kansas City, KS (2017 - present)
  • Pharmacy Research Staff, Dwight D. Eisenhower Veterans Affairs Medical Center, Leavenworth, KS (2015 - present)

Biography

Dr. Britt joined the faculty at the University of Kansas School of Pharmacy in August 2017. He is actively involved in clinical and translational research at the University of Kansas Medical Center and the Veterans Health Administration, where he holds a joint research appointment. Dr. Britt maintains an active clinical practice site on the inpatient infectious diseases consult service at the University of Kansas Hospital.

Research Overview

The Britt lab works along the clinical-translational science continuum to optimize the treatment of infectious diseases and sepsis. We use traditional in vitro pharmacokinetic (PK)/pharmacodynamic (PD) models of infection, as well as novel tools developed in our laboratory to identify more effective therapeutic strategies for combating multidrug-resistant infections. In addition, we study how the immune system responds to severe infection and how it can be modulated to improve patient outcomes.

Research Interests

  • Infectious Diseases
  • Immunology
  • Sepsis
  • Cystic Fibrosis
[field_sop_funding]

Selected Publications

Britt NS, Ritchie DJ, Kollef MH, et al. Importance of site of infection and antibiotic selection in the treatment of carbapenem-resistant Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother. 2018 Mar 27;62(4).

Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin Infect Dis. 2017 Mar 1;64(5):605-13.

Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3070-5.

Britt NS, Potter EM, Patel N, Steed ME. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis. 2015 Sep 15;61(6):871-8.
**Society of Infectious Diseases Pharmacists Pharmacotherapy Impact Paper of the Year (2016)
**ASHP Foundation Research Award (2016)

Awards & Honors

  • American Society of Microbiology Infectious Diseases Fellow (2017)
  • ASHP Foundation Research Award (2016)
  • St. Louis College of Pharmacy Research Award (2016)

2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to Kansans in need during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU
KU Today